Skip to main content

Table 5 Adjusted Odds Ratios (95% CI) of SCCHN for the p73 exon 2 G4A- p53 interaction analysis.

From: A case-control study on the combined effects of p53 and p73 polymorphisms on head and neck cancer risk in an Italian population

   p53 intron 3 (rs1788332) p53 intron 6 (rs1625895) p53 exon4 Arg72Pro (rs1042522)
   wt/wt mt carriers wt/wt mt carriers wt/wt mt carriers
  wt/wt 1* 1.05 (0.57–1.91) 1* 0.94 (0.53–1.68) 1* 0.92 (0.53–1.61)
  cases/controls 136/152 51/62 137/140 50/74 129/124 58/90
p73 exon 2 G4A mt carriers 1.25 (0.70–2.25) 2.22 (1.08–4.56) 1.49 (0.82–2.70) 1.50 (0.75–3.02) 1.33 (0.69–2.55) 1.63 (0.86–3.11)
(rs1801173/rs2273953) cases/controls 56/56 40/24 57/51 39/29 45/44 51/36
   p for interaction† = 0.30 p for interaction† = 0.89 p for interaction† = 0.55
  1. * = Reference category
  2. † = By likelihood ratio test